Procurement Summary
Country: Brazil
Summary: Srp for Future Drug Acquisitions
Deadline: 02 Dec 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 130175745
Document Ref. No.: 90162/2025
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - SRP for future drug purchases
UASG code: 180220
Notice from: 11/17/2025 from 08:00 to 11:59 and from 12:00 to 17:59
Proposal Delivery: from 11/17/2025 at 08:00
RADIOLOGICAL CONTRAST, COMPOSITION BASED ON BARIUM SULFATE, CONCENTRATION 100%, PHARMACEUTICAL FORM ORAL SUSPENSION
Quantity: 15
ETOPOSIDE, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION
Quantity: 100
CHLORPROMAZINE, DOSAGE 100 MG
Quantity: 400
METFORMIN HYCLORIDATE, CONCENTRATION 500 MG, PHARMACEUTICAL FORM PROLONGED ACTION
Quantity: 1500
TALC - USE PHARMACEUTICAL, PHYSICAL APPEARANCE WHITE POWDER, LIGHT, FINE, OIL TO THE TOUCH, LOW HARDNESS, CHEMICAL FORMULA 3MGO.4SIO2.H2O (MAGNESIUM SILICATE), PURITY DEGREE 100% PURITY, ADDITIONAL CHARACTERISTICS PRODUCT USP E STERILE, CHEMICAL REFERENCE NUMBER CAS 14807-96-6
Quantity: 100
FERRIC CHLORIDE, CONCENTRATION 50%, GEL PHARMACEUTICAL FORM, ADDITIONAL CHARACTERISTICS SPECIALLY MANIPULATED FORMULATION
Quantity: 10
IVERMECTIN, CONCENTRATION 6 MG
Quantity: 520
NEOSTIGMIN METHYLSULFATE, DOSAGE 0.5 MG/ML, INJECTABLE SOLUTION PRESENTATION
Quantity: 555
INSULIN, HUMAN ORIGIN, REGULAR TYPE, DOSAGE 100U/ML, INJECTABLE APPLICATION
Quantity: 150
POTASSIUM CHLORIDE, DOSAGE 6%, ORAL SOLUTION PRESENTATION
Quantity: 400
MEDICINAL ExTRACT, ACTIVE INGREDIENT BENJOIN, COMPOSITION STYRAx TOKINENSIS, CONCENTRATION 20%, PHARMACEUTICAL FORM TINTURE
FLUORESCEIN, 1% CONCENTRATION, SOLUTION APPLICATION OPHTHALMIC
Quantity: 30
PHENAZOPYRIDINE, DOSAGE 100 MG
Quantity: 250
TRICHLOROACETIC ACID (TCA), 70% CONCENTRATION, PHARMACEUTICAL FORM AQUEOUS SOLUTION
Quantity: 20
POLYMYxIN B, DOSAGE 500, 000UI, INJECTABLE PRESENTATION
Quantity: 2754
BUPIVACAINE HYCLORHYDRATE, PRESENTATION ASSOCIATED WITH GLUCOSE, DOSAGE 0.5% + 8%, INJECTABLE SOLUTION TYPE
Q...
Documents
Tender Notice